Pharmaceutical

The FDA had halted use in older adults while it investigated reports of side effects. The vaccine’s label now carries new warnings and restricts vacci...

While orforglipron succeeded in a Phase 3 trial, its weight loss effects were more modest than investors and analysts anticipated, leading to a sellof...

The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many pharmaceutical companies...

The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded to drugs like Keytruda.

Sarepta reported a quarter-on-quarter dip in sales for its Duchenne gene therapy. Elsewhere, Jazz won FDA approval of a brain cancer drug and Novo dec...

Decades-long research has yielded a strong and growing franchise built around drugs for a genetic form of lung cancer.

Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season

Four-year treatment slows cognitive decline with consistent safety profile Four-year treatment slows cognitive decline with consistent safety profile

MB310 study investigates safety and efficacy of precision microbiome therapy MB310 study investigates safety and efficacy of precision microbiome ther...

US$30.9 million strategic equity deal strengthens oncology platform US$30.9 million strategic equity deal strengthens oncology platform